Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
about
Recent developments and future prospects in the treatment of visceral leishmaniasisMiltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisLeishmania donovani develops resistance to drug combinationsSafety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trialEfficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized TrialLeishmaniasis: an update of current pharmacotherapy.Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.An update on pharmacotherapy for leishmaniasisGeneralizing boundaries for triangular designs, and efficacy estimation at extended follow-ups.Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection.Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapseTherapeutic options for visceral leishmaniasis.The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.Drug resistance in leishmaniasis: Newer developments.Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape.Chemotherapy of leishmaniasis: present challenges.Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine.Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.Visceral Leishmaniasis - Current Treatments and Needs
P2860
Q26740563-9CEA19CA-169E-4366-9B5C-F0390E19CCD6Q28088410-FBCCF3CD-6D3D-4F40-9A32-8E6C7E31448BQ28271849-973CFC05-B5E4-4E72-9D4C-B621ADB44C0BQ28484463-3E98BD46-DBD8-4D93-8AB9-01AFBFE6D06CQ28538775-3953F87F-1AA6-4FA2-A0D9-B4E88C870114Q28554069-36A15FA6-E850-401B-8267-9A7565CE56BBQ34318765-DECE6034-4D47-4BAA-A563-7FD75B643BE3Q34328882-9DA7E212-9920-438B-BF68-D359C5A52C1BQ34509079-27B3F93D-A3B9-4431-A80D-E488CC71F081Q34945204-8B97F79A-C83F-4A2D-A27B-8373AF25563CQ36287224-5F406940-501A-45B7-B2FC-B6AF657EA807Q36730131-8112EE76-D5B7-40A8-81FF-693CDF753B37Q36898219-E289189D-3523-4E33-9C74-7F6B5EB19CE6Q37333942-F3E02436-5FA8-4DCB-95FA-6955FC6CF0BAQ37372627-A1DCFE44-20B0-4501-8924-FC40745F28EDQ37544514-994CE1E7-267B-46B3-9292-2CAB53BBE4C7Q37712190-6AD87789-7625-42C2-9CF7-CCBBFADC12BEQ37712995-320003A2-B834-4DDF-9716-3FCDF6A78C38Q38296306-16436BD3-9CB0-49ED-81DF-EEAF0C0C943CQ39011875-5897CED8-F7CE-4814-817D-6A7DEE6A58F7Q39526125-AC2C5600-94B1-48BA-9CB6-392A84C728E1Q40802236-5FB71C8E-ADCB-4FD3-942F-CEFB89407CE3Q43577504-5BC60360-90EB-482D-A834-2EE22E464F11Q46380663-3825BF01-A9EE-45CA-A0E2-968702CA506DQ59003562-2A6D5A97-7F7C-4CE4-843F-3B797624F78A
P2860
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety and efficacy of miltefo ...... a randomized controlled trial.
@ast
Safety and efficacy of miltefo ...... a randomized controlled trial.
@en
type
label
Safety and efficacy of miltefo ...... a randomized controlled trial.
@ast
Safety and efficacy of miltefo ...... a randomized controlled trial.
@en
prefLabel
Safety and efficacy of miltefo ...... a randomized controlled trial.
@ast
Safety and efficacy of miltefo ...... a randomized controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Safety and efficacy of miltefo ...... a randomized controlled trial
@en
P2093
Abuzaid A Abuzaid
Ahmed M Musa
Brima M Younis
Dedan Kinoti
George Kirigi
Manica Balasegaram
Monique Wasunna
Neal Alexander
Njenga Njoroge
Raymond Omollo
P2860
P2888
P356
10.1186/1745-6215-12-166
P577
2011-06-30T00:00:00Z